Sector Update: Healthcare

01:05 PM EDT, 09/15/2026 (MT Newswires) -- Healthcare stocks were slightly higher Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each increasing about 0.1%. The iShares Biotechnology ETF (IBB) was down 1%. In corporate news, GSK (GSK) agreed to acquire global rights to an experimental T-cell engager therapy for multiple myeloma from Chinese biotechnology company Chimagen Biosciences in a deal worth up to $750 million, as the UK drugmaker aims to strengthen its blood cancer treatment portfolio. GSK shares were up 0.1%.